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OBJECTIVE: To identify the molecular genetic aetiology
of a family with autosomal dominant amelogenesis
imperfecta (AI).
SUBJECTS AND METHODS: DNA samples were col-
lected from a six-generation family, and the candidate
gene approach was used to screen for the enamelin
(ENAM) gene. Whole-exome sequencing and linkage
analysis with SNP array data identified linked regions,
and candidate gene screening was performed.
RESULTS: Mutational analysis revealed a mutation
(c.561_562delCT and p.Tyr188Glnfs*13) in the DLX3
gene. After finding a recurrent DLX3 mutation, the clini-
cal phenotype of the family members was re-examined.
The proband’s mother had pulp elongation in the third
molars. The proband had not hair phenotype, but her
cousin had curly hair at birth.
CONCLUSIONS: In this study, we identified a recurrent
2-bp deletional DLX3 mutation in a new family. The clin-
ical phenotype was the mildest one associated with the
DLX3 mutations. These results will advance the under-
standing of the functional role of DLX3 in developmen-
tal processes.
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Introduction
Tricho-dento-osseous (TDO) syndrome is a highly pene-
trant, rare autosomal dominant genetic disorder which is
characterized by inherited defects in the hair, tooth and
bones (Hart et al, 1997). Curly/kinky hair at birth,
hypoplastic enamel with less mineralization and thickening
of the cortical bones are the main features of TDO syn-
drome (Shapiro et al, 1983). Other clinical phenotypes
include brittle nails, mandibular prognathism and tau-
rodontism (Wright et al, 1997). A common mutation
responsible for TDO syndrome in the United States was
identified (Price et al, 1998a,b), and the mutation was a 4-
bp deletional mutation in the DLX3 gene
(c.571_574delGGGG and p.Gly191Argfs*66).
The hypomaturation and hypoplasia type of amelogene-
sis imperfecta with taurodontism (AIHHT) is a rare and
unique type of genetic disorder with defective tooth enamel
and elongated pulp chambers (Aldred et al, 2002). A 2-bp
deletional mutation (c.561_562delCT and p.Tyr188Gln-
fs*13) in the DLX3 gene was identified from an Australian
family with AIHHT by linkage analysis and candidate gene
sequencing (Dong et al, 2005). The affected individuals
exhibited only the dental phenotype including taurodon-
tism, without any hair and bone phenotypes. Subsequently,
the same mutation was identified in a Korean and a Cau-
casian family (Lee et al, 2008; Wright et al, 2008). The
affected individuals exhibited an enamel defect with pulp
enlargement and hair phenotypes but without a bone phe-
notype. Pulp enlargement was moderate but variable
among family members, and hair was curly and coarse.
The distal-less homeobox 3 (DLX3) gene is located on
chromosome 17q21 and has 3 exons (all coding). It encodes
a homeobox protein DLX3 that is 287 amino acids in
length. DLX3 contains the homeodomain sequence in the
middle of the protein (129–188 amino acids). The charac-
teristic homeodomain sequence usually consists of a 60-
amino acid-long helix-turn-helix structure with three alpha
helices (Banerjee-Basu and Baxevanis, 2001).
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Homeobox proteins can bind to DNA and regulate the
expression of targeted genes (Feledy et al, 1999). There-
fore, these proteins have essential roles during early
embryonic development and induce cellular differentiation
by regulating gene expression through their DNA-recogni-
tion properties (Merlo et al, 2000).
Because Dlx3 gene targeting in a mouse germ line
resulted in early embryonic death due to a placental defect
caused by altered development of the labyrinthine layer
(Morasso et al, 1999), conditional and/or targeted dele-
tions have been used to identify the functional roles of
DLX3 (Hwang et al, 2008; Lezot et al, 2008; Duverger
et al, 2012, 2013). DLX3 has an essential role during the
development of hair follicles, bone, enamel and dentin.
In this study, we identified a family with amelogenesis
imperfecta with hypomaturation and hypoplastic type but
seemingly lacking any other clinical phenotypes. Muta-
tional analysis identified the same 2-bp deletional DLX3
mutation through a long roundabout way. This family
could represent the mildest clinical phenotype associated
with a recurrent DLX3 mutation.
Materials and methods
Recruitment of the family
The protocol of this study was independently reviewed and approved by
the institutional review board of the Seoul National University Dental
Hospital and the University of Istanbul. The participating individuals
were informed of the study and agreed to participate. Clinical examina-
tions and blood collections were performed with written consent accord-
ing to the Declaration of Helsinki.
DNA isolation and candidate gene sequencing
DNA was isolated from peripheral whole blood with the QuickGene
DNA whole blood kit S (Fujifilm, Tokyo, Japan). The quantity and
quality of the DNA were measured with spectrophotometry by the
OD260/OD280 ratio. Candidate gene sequencing of the exons and adjacent
intron sequences of the ENAM gene were performed using the DNA of
the proband. PCR amplifications were performed according to a previous
report (Kim et al, 2005) with the HiPi DNA PCR premix (ElpisBio, Tae-
jeon, Korea). The amplification products were purified with a PCR purifi-
cation kit (ElpisBio) and submitted to a DNA sequencing centre for
sequencing (Macrogen, Seoul, Korea). Mutation Surveyor (SoftGenetics,
State College, PA, USA) was used for sequence analyses.
Whole-exome sequencing
The DNA samples of two affected (V:8 and VI:7) and one unaffected
(V:9) individuals were captured with SureSelect Target Enrichment Sys-
tem (Agilent Technologies, Santa Clara, CA, USA). Ninety-bp paired-end
sequencing reads were generated with the Illumina HiSeq 2000. The Bur-
row–Wheeler Aligner was used to align the sequencing reads to the
human reference genome (NCBI build 37.2, hg19). After series of bioin-
formatic analyses with SAMtools and GATK (Li et al, 2009; McKenna
et al, 2010), single-nucleotide variants and short insertions/deletions were
obtained. The single-nucleotide polymorphism database (dbSNP build
138) was used to annotate the sequence variations.
SNP array and linkage analysis
SNP array analysis was performed for all participating members (four
affected and seven unaffected). Data obtained from the Affymetrix Gen-
ome-Wide Human SNP array 6.0 (DNA LINK Inc., Seoul, Korea) were
used to detect any pathologic copy number variations (deletion or dupli-
cation). SNPs were annotated for all individuals, and linkage analysis
was performed with Superlink online SNP ver. 1.1 (http://cbl-hap.cs.tech
nion.ac.il/superlink-snp/) (Silberstein et al, 2013).
Polymerase Chain Reaction (PCR) and sequencing
The identified variation in the DLX3 gene was confirmed with Sanger
sequencing, and segregation within family was confirmed with primers
previously described (DLX3 exon 3; sense: 50-ATT
GGGTTCTGGCCTTTCTT, antisense: 50-GCCTTCTGCCTGGTCCTG)
(Kim et al, 2006). PCR amplification and sequencing were performed as
described above.
Results
The proband was a 9-year-old female (Figure 1a). Accord-
ing to the six-generation family pedigree, it was obvious
that the disease was transmitted as an autosomal dominant
inheritance pattern, based on the male-to-male transmis-
sion. The proband had localized enamel hypoplasia with





Figure 1 Pedigree, clinical photographs and
panoramic radiograph of the family. (a) The
disease was transmitted to the proband (VI:3)
from her father (V:7). The + symbols indicate
family members who participated in this study.
(b–d) Clinical photographs of the proband at
age 9. Localized enamel hypoplasia was noted
on the labial sides of the anterior teeth and
hypomaturation in the molar teeth caused
excessive attrition. (e) Panoramic radiograph of
the proband (VI:7) at age 13. There was no
taurodontic feature in any tooth.
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other medical conditions (Figure 1b–e). There were no
other clinical symptoms in the hair, nails and bones.
Therefore, we screened for the ENAM gene as a candi-
date gene approach, based on the autosomal dominant
inheritance and hypoplastic enamel defect. Candidate
sequencing of the ENAM gene did not reveal any patho-
logic variations. Then, we did whole-exome sequencing
and analysed data with conventional filtering conditions
for SNP and indel calling. Candidate variants, which were
common in the affected individuals but not present in the
unaffected individual, were selected and tested for all par-
ticipating family members. However, no candidate variant
was found to cosegregate with the disease phenotype in
the family.
Multipoint linkage analysis was performed to locate the
chromosomal region linked to the disease, even though the
maximum LOD score would be <3 with a limited number
of family members. Among the five linked regions obtained
with a maximum LOD score of 2.1 (Figure S1), chromo-
some 17 had the longest linked region spanning 17.5 cM
(chr17:29,784,258–49,844,513) (Figure 2). Whole-exome
data were re-analysed without any filtering options. Variants
within the linked regions were searched, and a recurrent 2-bp
deletional variant (c.561_562delCT and p.Tyr188Glnfs*13)
in the DLX3 gene was identified. Sanger sequencing of all
family members confirmed this variant as a disease-causing
mutation in this family.
After finding the mutation, the clinical phenotype of the
affected individuals was re-examined (Figure 3). The pro-
band’s father (V:7), who was 35 years old, had lost many
teeth and wore partial dentures. Panoramic radiograph and
clinical examination showed thin enamel with less miner-
alization. The proband’s aunt (V:8), who was 33 years
old, also had generalized enamel hypoplasia with hypo-
maturation. Her third molars showed elongated pulp
chambers. Panoramic radiograph of the proband’s cousin
(VI:7) revealed slight elongation of the pulp chamber in
the left second permanent molars. A cephalometric radio-
graph, taken at age 16, showed no bone-related abnormal-
ity, including increased bone density or sclerotic changes.
The proband’s hair was not curly at birth, but her cousin
had curly hair at birth but is now less curly.
Discussion
Among the clinical phenotypes, the enamel defect is the
most constant feature of TDO syndrome. The thin and less
mineralized enamel results in discoloration and excessive
Figure 2 Mutational analysis. Superlink online
analysis revealed linkage to the long region of
the chromosome 17 with a LOD score of 2.1.
The linked region is shown below the LOD
plot. The DLX3 gene is located within the
linked region, shown with the Integrated
Genome Viewer 2.3. Sanger sequencing
chromatogram of a wild-type individual (VI:6)
is shown above, and the chromatogram of the
proband is shown below. The position of the
deletion is indicated by a red arrow.
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attrition, causing an early destruction of the tooth materi-
als and pathologic pulp involvement (Hyun and Kim,
2009). The expression of DLX3 has been shown in both
tooth epithelium and mesenchyme (Zhang et al, 2015).
Especially, DLX3 is constantly expressed in the ameloblast
throughout all amelogenesis processes (presecretory, secre-
tory and maturation stages) (Ghoul-Mazgar et al, 2005).
Therefore, a defective DLX3 can affect both the thickness
and degree of maturation of the enamel.
DLX3 has three main domains: an N-terminus and C-
terminus transactivation domain and a central home-
odomain. The homeodomain can directly interact with
DNA in a sequence-specific manner and regulates the
expression of target genes during many development pro-
cesses (Feledy et al, 1999). The deletion of the transacti-
vation domain has been shown to cause the loss of Dlx3
function as a transcription factor, indicating that these sub-
domains have important roles in homeodomain-DNA
binding (Feledy et al, 1999).
To date, six DLX3 mutations are known to exist
(Table 1). In general, missense mutations, which change
conserved amino acids in the homeodomain (129–188
amino acids), result in the most severe clinical phenotypes
(Mayer et al, 2010; Nieminen et al, 2011; Li et al, 2015).
In addition to the tooth phenotypes including enamel
hypoplasia and hypomaturation, defective dentin formation
and taurodontic features, the hair and bone phenotypes are
usually clearly manifested in these cases. In some cases,
the hair is sparse, resembling lanugo or uncombable
(Mayer et al, 2010; Nieminen et al, 2011). It is believed
that these clear phenotypes are caused by the loss of the
DNA-binding ability due to missense mutations.
The first identified 4-bp deletional mutation
(c.571_574delGGGG and p.Gly191Argfs*66) right after
the homeobox region is the most common aetiology in
Virginia and North Carolina TDO families and transmitted
from a common ancestor (Price et al, 1998a). The clinical
variability is believed to be from environmental factors
and/or other genetic modifiers (Price et al, 1998b). This
mutation does not change the homeodomain but results in
frameshift changing a glycine at the 191 amino acid posi-
tion to arginine and encodes a novel 65 amino acid
sequence instead of a normal 97 amino acid sequence.
The 2-bp deletional mutation (c.561_562delCT and
p.Tyr188Glnfs*13) has been identified in multiple families
with different ethnicities, indicating this is a mutational
hotspot in the DLX3 gene (Dong et al, 2005; Lee et al,
2008; Wright et al, 2008). However, clinical phenotypes
are different among the families with different ethnicity.









Figure 3 Clinical photographs and radiograph
of the other affected individuals. (a–d) Clinical
photographs and panoramic radiograph of the
proband’s father (V:7) at age 35. He retained
only several teeth and wore partial dentures.
Remaining teeth also showed general
destruction with attritions due to
hypomineralization and hypoplasia. (e–h)
Clinical photographs and panoramic radiograph
of the proband’s aunt (V:8) at age 33. Her
dentition also showed excessive attrition and
discoloration due to hypomaturation and
hypoplasia of the affected enamel. Remaining
third molars showed elongated pulp chambers.
(i–l) Clinical photographs of the proband’s
cousin (VI:7) at age 11 and panoramic
radiograph at age 15. Hypoplastic enamel with
hypomaturation resulted in excessive attrition
and discolorations, especially in the posterior
teeth. Left second permanent molars had slight
pulp chamber elongation. (m) Cephalometric
radiograph of the proband’s cousin (VI:7) at
age 16. There was no bone-related abnormality,
including increased bone density or sclerotic
changes.
Oral Diseases
A recurrent DLX3 mutation
Y.-J Kim et al
300
and bone phenotypes (Aldred et al, 2002), but two other
families (Korean and Caucasian) exhibited attenuated phe-
notype of TDO syndrome (Lee et al, 2008; Wright et al,
2008). In this report, we identified the same mutation in a
Turkish family. The clinical phenotype was the mildest
among the families with the same mutation. There was no
bone-related phenotype, and pulp enlargement was absent
or minimal except for the third molars. The proband did
not have curly hair, but another affected individual had
curly hair at birth. The clinical variability among families
with the same 2-bp deletional mutation could be from the
environmental and/or other genetic modifiers as in the
cases of the 4-bp deletional mutation. However, it is obvi-
ous that the 2-bp deletional mutation is milder than the
other mutations.
How can we explain the mild phenotype of the recur-
rent 2-bp deletional DLX3 mutation? The CT deletion
results in a frameshift changing a tyrosine at the 188
amino acid position, the last amino acid in the homeobox,
to glutamine and encodes a novel 12 amino acid sequence
instead of a normal 100 amino acid sequence. Both dele-
tional mutations have a normal N-terminal domain and
homeodomain. With an intact nuclear localization signal
in the homeobox domain, these two truncated DLX3
would translocate into the nucleus (Nieminen et al, 2011).
Without a normal C-terminus transactivation domain, both
mutant DLX3s would lose their transcriptional activity by
themselves. However, it is well known that certain tran-
scription factors can interact to modulate developmental
processes (Jolma et al, 2015). Therefore, the shorter C-
terminal novel sequence from the 2-bp deletion would
result in less harmful effects than that of the longer one
from a 4-bp deletion for the interactions between tran-
scription factors, resulting in a milder phenotype.
In conclusion, we identified a recurrent 2-bp deletion in
the DLX3 gene in a new family and described their mild
clinical phenotype related to the DLX3 mutation. Further
molecular genetic and functional biochemical studies
would be necessary to better understand the essential
developmental role of normal and mutant DLX3 proteins.
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